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Crystal structure of a substrate-
free aspartate transporter










Glutamate transporters are secondary transporters found in many 
eukaryotes, bacteria and archaea1. In prokaryotes these transporters 
mediate the uptake of nutrients, whereas in mammals, where gluta-
mate is a major excitatory neurotransmitter, they catalyze the neuro-
transmitter reuptake into neurons and glial cells that follows synaptic 
signal transduction. Maintaining a low extracellular concentration 
of the neurotransmitter is essential for sensitive signal transmission 
and for the prevention of neurotoxicity. The transporters couple the 
uptake of glutamate to the symport of cations: three sodium ions and 
one proton are co-transported by the neuronal and glial transport-
ers2. After the substrate and cations are released into the cytoplasm, 
the empty binding site reorients to an outward-facing orientation. 
In mammalian transporters this reorientation is strictly coupled to 
the export of a potassium ion, but in prokaryotes no such coupling 
is required3.
Structural information is available for the glutamate transporter 
homolog GltPh from the archaeon Pyrococcus horikoshii, which is 
selective for aspartate rather than glutamate and which couples the 
uptake of substrate to the symport of three sodium ions3–8. The protein 
is a homotrimer, with each protomer consisting of two domains. The 
trimerization domain mediates the subunit contacts, and the trans-
port domain carries the binding sites for aspartate and sodium ions. 
Different crystal structures of substrate-bound GltPh have revealed 
that the trimerization domains form a stable scaffold6,9. The transport 
domains have been captured in three states: outward facing, interme-
diate and inward facing5–7. The structures suggest that the transport 
domains behave as rigid bodies and move across the membrane like 
an elevator to shuttle the substrate and coupled ions from one side to 
the other. Because the transporters are substrate loaded in all available 
crystal structures, the mechanism by which the empty (substrate-free) 
transporter reorients to the outward-facing position after delivery of 
the substrates to the cytoplasm remained elusive. To gain insight into 
this essential part of the transport cycle, we determined the structure 
of a substrate-free transporter.
We purified glutamate transporter homologs from several closely 
related Archaea, using a protocol that yields the protein devoid of 
aspartate and sodium ions8 (see also Online Methods). The rea-
son that we did not focus exclusively on GltPh was to increase our 
chances of obtaining well-diffracting crystals. We obtained pure 
and stable preparations of GltTk from the thermophilic archaeon 
T. kodakarensis. GltTk shares 77% sequence identity with GltPh, and all 
residues that interact with the substrate aspartate in GltPh are strictly 
conserved in GltTk (Supplementary Fig. 1). The residues that shape 
the two Na+-binding sites found in the GltPh crystal structures are 
also conserved. The location of the third Na+-binding site is still 
debated10–12. The two transporters are functionally similar as well. 
Just like GltPh (ref. 3), GltTk is a sodium-coupled aspartate trans-
porter that also accepts d-aspartate but not glutamate as substrate 
(Supplementary Fig. 2). Importantly, we confirmed by isothermal 
titration calorimetry that our preparations of GltTk were free of Na+ 
and aspartate (Supplementary Fig. 3).
We solved the structure of apo-GltTk to a resolution of 3.0 Å (see 
Supplementary Table 1 for data collection and refinement statistics). 
The extensive sequence similarity between GltPh and GltTk, as well as 
their functional resemblance, allowed for a comparison between the 
substrate-bound structures available for GltPh and the structure of 
the apoprotein of GltTk. The overall structure of GltTk is very similar 
to that of GltPh, with the transport domain in the outward-facing 
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Figure 1 Aspartate-binding site. (a) Comparison of the aspartate-binding 
sites in GltPh and GltTk. Relevant amino acid residues are shown as sticks 
and labeled and numbered as in GltTk (and as in GltPh in parentheses). 
GltPh is colored in gray, the substrate l-aspartate from GltPh in light red 
and GltTk in orange. The large shift of Arg401(397) in TMS 8 is indicated 
with an arrow. (b) Stereo image of the substrate-binding site of GltTk with 
electron density (2Fo – Fc map, contoured at 1.2σ). GltTk is shown in 
orange, and the substrate l-aspartate present in GltPh is shown in light red 
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conformation (Supplementary Fig. 4a)4,5. The two helical hairpins 
(HP1 and HP2) in the transport domain, which may form intra- and 
extracellular gates, respectively, occlude the substrate-binding site in 
both GltPh and GltTk (Supplementary Fig. 4b).
Despite these similarities in global structure, there are crucial dif-
ferences in the binding sites for aspartate and sodium ions. In the 
 aspartate-binding site, Arg401 of GltTk in transmembrane segment 
(TMS) 8 adopts a very different conformation from the equivalent 
Arg397 of GltPh (Fig. 1). This arginine is highly conserved in the gluta-
mate transporter family and is essential for transport13–15. Compared to 
that in GltPh, the guanidium group of Arg401 in GltTk is offset by ~4 Å, 
and its position overlaps that occupied by the substrate aspartate in 
GltPh. Thus, in the empty carrier, the side chain of a highly conserved 
residue takes over the site occupied by the transported ligand in the 
loaded carrier. Because the overlap is not complete, we assume that 
water molecules fill up the rest of the empty binding site. The position 
of the guanidium group of Arg401 is stabilized by an ionic interaction 
with conserved Asp398 (394, where the numbering in parentheses is 
for GltPh). In substrate-bound GltPh this residue interacts with the 
amino group of the substrate aspartate (Supplementary Fig. 5). The 
side chain B-factors of Arg401 are slightly higher than the average 
in the protein (Supplementary Table 2); this could be related to the 
dynamic role of Arg401, which should be able to reposition during 
the translocation cycle.
The repositioning of Arg401 has another consequence as it breaks 
the cation-π interaction with Tyr320 (317) in TMS7 that is present 
in substrate-bound GltPh (ref. 4). This breakage allows for rearrange-
ments in TMS7, notably of Tyr320 (317), Gln321 (318) and Thr317 
(314) (Fig. 2a). In GltPh the location of the latter residue is stabilized 
by a hydrogen bond with the α-carboxylate of the substrate aspar-
tate, but in the substrate-free transporter it can reorient, which also 
affects the region around Met314(311) in TMS7 (see below). In the 
rat transporter GLT-1, the equivalents of Tyr320 and Gln321 (Tyr403 
and Glu404, respectively) are essential for the coupling with potas-
sium ions, which is required for reorientation of the empty carrier 
in mammalian glutamate transporters16,17. The rearrangement of 
residues around Arg401 in apo-GltTk creates a pocket, which in the 
mammalian transporters may form a potassium-binding site (Fig. 2a). 
The structure provides an explanation for a key finding in the 
neuronal glutamate transporter EAAC1. When the equivalent of 
Arg401 (Arg447 in EAAC1) was mutated into cysteine, the protein 
could no longer bind or transport glutamate and aspartate, but it was 
still able to transport neutral amino acids. However, only exchange 
of the neutral amino acids could take place, and net transport was 
impaired, showing that the conserved arginine is crucial not only for 
the binding of acidic substrates but also for the reorientation of the 
empty carrier15.
In both GltTk and GltPh, TMS7 is partially unwound in the center of 
the membrane. The unwound part in GltTk has undergone a dramatic 
change of conformation around Met314, which is a highly conserved 
and functionally important residue14,18. The side chain of Met314 in 
the empty transporter points away from the binding site (Fig. 2b–d) 
a b
dc
Figure 2 Cation-binding sites. (a) Overlay of GltTk, in orange, with GltPh, 
in gray (the substrate l-aspartate is shown in light red). The cation-π 
interaction between Arg397 and Tyr317 of GltPh is disrupted in GltTk 
and a cavity is created, which could form a potassium-binding site in the 
eukaryotic members of the glutamate transporter family. Numbering of 
residues is for GltTk, with numbers for GltPh in parentheses. (b) Electron 
density of HP2 (2Fo – Fc map, contoured at 1.2σ). (c,d) Comparison  
of Na+-binding sites of GltPh (c, in gray) with GltTk (d, in orange).  
The two Na+-binding sites of GltPh are indicated 1 and 2. Relevant 
residues are labeled and numbered according to the GltPh or GltTk 



















Figure 3 Translocation cycle of archaeal aspartate transporters based 
on the available crystal structures. Shown (clockwise from top right) are 
surface representations of a single subunit of the trimeric protein in the 
outward-facing substrate-loaded (PDB 2NWL)5, intermediate substrate-
loaded (PDB 3V8G)7, inward-facing substrate-loaded (PDB 3KBC)6 and 
outward-facing substrate-free (current structure) states. No structures are 
available for the inward-facing and intermediate states of the substrate-
free transporters. The trimerization domain is in yellow, the transport 
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and is exposed to the lipid bilayer between Leu92 of TMS3 and Val349 
of HP2. In GltPh the side chain of the equivalent Met311 points toward 
the binding site and is located between the two sodium-binding sites 
that were found in the GltPh crystal structures.
The change in conformation of the unwound part of TMS7 in GltTk 
directly affects the first Na+-binding site, as the backbone carbonyl 
oxygen of Asn313 (310) is displaced and is no longer in a favorable 
position to coordinate a sodium ion. Similarly, the carbonyl oxygen 
of Asn405 (401) in GltTk is not properly oriented to bind the sodium 
ion. The second Na+-binding site is also deformed in GltTk. The 
backbone carbonyls of Ser352, Ile353 and Thr355 in HP2 that coor-
dinate the second sodium ion in the GltPh structure are displaced 
by 4 Å, 1.8 Å and 4.5 Å in GltTk, thus impeding the binding of the 
cation (Fig. 2b–d).
The structure of apo-GltTk provides an explanation for the mech-
anism of reorientation of the empty carrier. Because the overall 
structures of both the trimerization and the transport domains 
of the apoprotein are very similar to those of the correspond-
ing domains in the substrate-loaded GltPh, it is plausible that the 
movement of the transport domain across the membrane will take 
place in the empty carrier in the same manner as it does in the 
loaded carrier (Fig. 3). This hypothesis is supported by recent EPR 
experiments on GltPh, which showed that the transport domain is 
structurally heterogeneous both in the apo and in the substrate-
bound transporter, indicating a movement across the membrane in 
both conditions19,20.
MeTHods
Methods and any associated references are available in the online 
version of the paper.
Accession codes. Atomic coordinates and structure factors for the 
Thermococcus kodakarensis GltTk transporter in its substrate-free state 
are deposited in the Protein Data Bank under accession code 4KY0.
Note: Any Supplementary Information and Source Data files are available in the online 
version of the paper.
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oNLINe	MeTHods
Chemicals. Restriction enzymes and antarctic phosphatase were purchased 
from New England BioLabs Inc., T4 DNA ligase from Thermo Scientific, 
l-[14C]aspartate (1.85 MBq, 7.4 GBq/mmol) from PerkinElmer and lipids 
from Avanti Polar Lipids Inc. l-Arabinose and ampicillin sodium salt were from 
Sigma-Aldrich. All chemicals were analytical purity grade.
DNA manipulation, protein purification and concentration determination.  
C-terminally His8-tagged GltTk was purchased from Geneart. GltTk was cloned 
into the pBAD24 vector using standard cloning methods. Escherichia coli MC1061 
cells containing the plasmid were cultivated in LB medium (37 °C and 200 r.p.m.), 
and protein was produced by inducing cells at an OD600 of 0.8 with 0.05%  
l-arabinose for 3 h. Harvesting, membrane vesicle preparation, determination of 
total protein concentration and solubilization in n-dodecyl-β-d-maltopyranoside 
were done as described before8. To obtain apo-GltTk, we used the procedure that 
also yielded apo-GltPh, with minor modifications as described below8. The crucial 
difference between this purification procedure and the one used by the Gouaux 
and Boudker labs4 is the omission of Na+ from all buffers. In sodium-containing 
buffers, the substrate aspartate remains associated with the protein throughout 
the entire purification because the koff is very low. In the absences of sodium 
ions, the substrate aspartate is lost during the purification. After solubilization, 
the solution was subjected to ultracentrifugation for 30 min at 4 °C, 265,000g. The 
supernatant was incubated for 1 h on a rotating platform at 4 °C with 0.5 mL bed 
volume Ni-Sepharose (GE Healthcare) pre-equilibrated with 50 mM Tris HCl, 
pH 8, 300 mM KCl, 0.15% n-decyl-β-d-maltopyranoside (DM), 15 mM imidazole, 
pH 8. The solution was then loaded onto a Poly-Prep chromatography column 
(Bio-Rad), which was washed with 20 column volumes (CV) of 50 mM Tris HCl, 
pH 8, 300 mM KCl, 0.15% DM, 60 mM imidazole, pH 8. GltTk was eluted with 
50 mM Tris HCl, pH 8, 300 mM KCl, 0.15% DM, 500 mM imidazole, pH 8. 
The protein was further purified by size exclusion chromatography (SEC) on a 
Superdex 200 10/300 GL (GE Healthcare) column using 10 mM HEPES-KOH, 
pH 8, 100 mM KCl, 0.15% DM as running buffer. For crystallization trials the 
peak fractions were used. After purification, the protein concentration was deter-
mined by UV absorption (NanoDrop), using the molecular weight and extinction 
coefficient calculated by the ExPASy ProtParam tool (web.expasy.org/protparam/). 
The protein was concentrated to ~7 mg/mL using a spin concentrator (Vivaspin 2, 
30,000 MWCO, PES membrane, Vivaproducts).
Crystallization and structure determination. The best diffracting crystals were 
obtained by the vapor diffusion method in hanging drop with a protein con-
centration of 7 mg/mL and a reservoir solution of 25% glycerol/polyethylene 
glycol (PEG) 4000/glycerol, 100 mM Tris/bicine, pH 8.5, 60 mM CaCl2/MgCl2 
and 0.5% n-octyl-β-d-glucopyranoside (OG). Data sets were collected at ESRF 
beamlines ID 23-1 and ID 29.
Data processing was performed with XDS with the highest resolution limit of 
3.0 Å. The structure was solved with Phaser software using only one monomer 
of GltPh (PDB 2NWX) as a search model. The refinement was done in PHENIX 
with application of NCS and TLS restraints. To remove bias, several rounds of 
simulated annealing were performed. Manual correction and building was per-
formed in Coot. Structural figures were generated with PyMOL.
Reconstitution and activity assays. GltTk was reconstituted into liposomes 
consisting of a 3:1:1 mixture of 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine 
(DOPE):1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC):1,2-di-(9Z- 
octadecenoyl)-sn-glycero-3-phospho-(1′-rac-glycerol) (DOPG) according to 
Hänelt19. Transport assays were performed essentially as described before8. All 
assays were done at 30 °C with stirring, under iso-osmotic conditions. External 
buffer (50 mM sodium phosphate, pH 6, 7 or 8; or 50 mM Tris/MES, pH 6, 7 
or 8), supplemented with 0.23 µM l-[14C]aspartate (PerkinElmer) and 0.6 µM 
valinomycin was mixed with the proteoliposomes containing 1 µg GltTk in a 100:1 
(v/v) ratio. For substrate competition experiments a 400-fold excess of unlabeled 
l-aspartate, d-aspartate or l-glutamate was added to the external buffer. 200-µL 
samples were taken at each time point, transferred immediately into 2 mL ice-
cold outside buffer and filtered over a 0.45-µm-pore-size filter (Protran Ba 85, 
Whatman). The filters were transferred to a 2-mL reaction tube, 2 mL scintilla-
tion liquid (Emulsifier Scintillator Plus, PerkinElmer) was added and the filters 
were allowed to dissolve. All samples were measured in a PerkinElmer Tri-Carb 
2800RT liquid scintillation counter.
ITC. ITC experiments were performed at a constant temperature of 25 °C using 
an ITC200 calorimeter (MicroCal). The thermally equilibrated ITC cell was filled 
with 200 µl of purified GltTk (concentration 13–15 µM, in 10 mM HEPES/KOH, 
pH 8, 100 mM KCl, 0.15% DM with or without 500 mM NaCl). 100 µM aspartate 
(dissolved in the same buffer as the protein) was titrated into the cell in steps of 
2 µL. Data was analyzed using the software provided by MicroCal.
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